Characteristics of rifampicin-resistant tuberculosis detection in China, 2015–2019

Characteristics of rifampicin-resistant tuberculosis detection in China, 2015–2019

Abstract Background The very high burden of rifampicin resistance tuberculosis (RR-TB) and the very low detection of RR-TB cases are a major challenge that China has been facing. This study analyzed the characteristics of RR-TB detection in China after the change of RR-TB detection strategy since 20...

Full description

Bibliographic Details
Main Authors:	Wei Su, Yun-zhou Ruan, Tao Li, Xin Du, Jia-wen Jiang, Ren-zhong Li
Format:	Article
Language:	English
Published:	BMC 2021-07-01
Series:	Infectious Diseases of Poverty
Subjects:	Rifampicin-resistant tuberculosis Case detection Detection policy China
Online Access:	https://doi.org/10.1186/s40249-021-00883-8

Similar Items

Recurrence Is a Noticeable Cause of Rifampicin-Resistant Mycobacterium tuberculosis in the Elderly Population in Jiangxi, China
by: Qiang Chen, et al.
Published: (2019-07-01)

Poor response to tuberculosis treatment with regimens without rifampicin in immunosuppressed AIDS patients
by: M.M. O'Donnel, et al.

Poor response to tuberculosis treatment with regimens without rifampicin in immunosuppressed AIDS patients
by: O'Donnel M.M., et al.
Published: (2002-01-01)

Rifampicin resistance in new bacteriologically confirmed pulmonary tuberculosis patients in Cameroon: a cross-sectional survey
by: J. Noeske, et al.
Published: (2018-08-01)

Rapid molecular detection of rifampin resistant tuberculosis in Basrah Governorate – South of Iraq
by: A A Al-Mussawi, et al.
Published: (2015-01-01)

Can diabetes mellitus modify the plasma concentrations of rifampicin in patients under treatment for tuberculosis?
by: Adriana Aparecida Durães Fonseca, et al.
Published: (2020-07-01)

Detection of Rifampicin Resistance in HIV Seropositive Individuals with Suspected Pulmonary Tuberculosis by Using CBNAAT
by: Shilpa, et al.
Published: (2017-03-01)

Rifampicin-Induced Thrombocytopenia: A Rare Complication
by: Ravi Dosi, et al.
Published: (2019-01-01)

Tuberculosis-HIV treatment with rifampicin or rifabutin: are the outcomes different?
by: Carolina Arana Stanis Schmaltz, et al.
Published: (2019-02-01)

Rifampicin-induced acute thrombocytopenia
by: Banu Rekha V, et al.
Published: (2005-01-01)

Molecular quantification of Rifampicin-resistance in Mycobacterium tuberculosis
by: Abdulameer Abuallh Al-Mussawi, et al.
Published: (2017-07-01)

Sputum culture and drug sensitivity testing outcome among X-pert Mycobacterium tuberculosis/rifampicin-positive, rifampicin-resistant sputum: A retrospective study — Not all rifampicin resistance is multi-drug resistant
by: Lebogang Kenaope, et al.
Published: (2020-06-01)

Effectiveness of highly active antiretroviral therapy (HAART) used concomitantly with rifampicin in patients with tuberculosis and AIDS
by: Flávia Marinho Sant'Anna, et al.

Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at University of Gondar Hospital, northwest Ethiopia
by: Jaleta KN, et al.
Published: (2017-06-01)

Rifampicin resistance in mycobacterium tuberculosis patients using GeneXpert at Livingstone Central Hospital for the year 2015: a cross sectional explorative study
by: Sepiso K. Masenga, et al.
Published: (2017-09-01)

Adrenal function in hospitalised patients with pulmonary tuberculosis treated with rifampicin
by: Venter, Willem Daniel Francois
Published: (2009)

Isoniazid resistance among rifampicin-susceptible Mycobacterium tuberculosis isolates from tuberculosis patients
by: Jyoti Arora, et al.
Published: (2016-01-01)

Development of Pseudomembranous Colitis Four Months after Initiation of Rifampicin
by: Jeong Moon Choi, et al.
Published: (2011-01-01)

Rifampicin resistance in Mycobacterium tuberculosis in Iran: a two-centre study
by: F. Bahraminia, et al.
Published: (2021-07-01)

Sequence Analysis of Rifampicin Resistance Determining Region (RRDR) of Mycobacterium tuberculosis
by: Mitesh Shrestha, et al.
Published: (2018-01-01)

Prevalence of mutations in Mycobacterium tuberculosis genes coding resistance to isoniazid and rifampicin in tuberculosis patients from different age groups
by: T. Yu. Salina, et al.
Published: (2019-05-01)

Rifampicin-Resistant Mycobacterium tuberculosis Among Patients with Presumptive Tuberculosis in Addis Ababa, Ethiopia
by: Araya S, et al.
Published: (2020-10-01)

Efficacy of Combined Rifampicin Formulations Delivered by the Pulmonary Route to Treat Tuberculosis in the Guinea Pig Model
by: Lucila Garcia-Contreras, et al.
Published: (2021-08-01)

Can the duration of tuberculosis treatment be shortened with higher dosages of rifampicin?
by: Noton K. Dutta, et al.
Published: (2015-10-01)

Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China
by: Zheyuan Wu, et al.
Published: (2020-02-01)

Relative Bioavailability of Rifampicin in Four Chinese Fixed-dose Combinations Compared with Rifampicin in Free Combinations
by: Hui Zhu, et al.
Published: (2015-01-01)

Rarity of rpoB Mutations Outside the Rifampicin Resistance-Determining Region of Mycobacterium tuberculosis Isolates from Patients Responding Poorly to First-Line Tuberculosis Regimens in Beijing, China: A Retrospective Study
by: Guo J, et al.
Published: (2021-07-01)

Efavirenz Plasma Concentrations and HIV Viral Load in HIV/AIDS-tuberculosis Infection Patients Treated with Rifampicin
by: Nina Mariana, et al.
Published: (2016-09-01)

Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management
by: Rajendra Prasad, et al.
Published: (2018-01-01)

Rifampicin resistance among patients with Tuberculosis at the Olabisi Onabanjo University Teaching Hospital, Sagamu
by: Daniel Olusoji James, et al.
Published: (2018-06-01)

Pyrosequencing for rapid detection of tuberculosis resistance to Rifampicin and Isoniazid in Syrian and Lebanese clinical isolates
by: M Hamze, et al.
Published: (2015-01-01)

Enhancing antimycobacterial activity of isoniazid and rifampicin incorporated norbornene nanoparticles
by: Kalaiselvi Kumarasingam, et al.
Published: (2018-01-01)

Rifampicin-resistant tuberculosis in Iran: A systematic review and meta-analysis
by: Farhad Bahraminia, et al.
Published: (2021-06-01)

Evaluation of GeneXpert Mycobacterium tuberculosis/Rifampin for the detection of Mycobacterium tuberculosis complex and rifampicin resistance in nonrespiratory clinical specimens
by: Maya Habous, et al.
Published: (2019-01-01)

GENEXPERT OF CERVICAL LYMPH NODE SPECIMENS IN THE DIAGNOSIS OF EXTRAPULMONARY TB AND RIFAMPICIN RESISTANCE
by: Niaz Hussain Soomro, et al.
Published: (2017-08-01)

Rifampicin-Carbohydrate Spray-Dried Nanocomposite: A Futuristic Multiparticulate Platform For Pulmonary Delivery
by: Mehanna MM, et al.
Published: (2019-11-01)

Rifampicin-induced interstitial nephritis: A case report and a short review of the literature
by: Ghouse Ahmed Khan, et al.
Published: (2016-07-01)

LipF increases rifampicin and streptomycin sensitivity in a Mycobacterium tuberculosis surrogate
by: Ana Leticia Arriaga-Guerrero, et al.
Published: (2020-05-01)

Epidemiological profile of patients with rifampicin-resistant tuberculosis: an analysis of the Uganda National Tuberculosis Reference Laboratory Surveillance Data, 2014–2018
by: Gloria Bahizi, et al.
Published: (2021-05-01)

Predictors of lethal outcome in patients with tuberculosis, resistance to rifampicin, and HIV infection
by: S. S. Saenko, et al.
Published: (2020-06-01)